ClinicalTrials.Veeva

Menu

Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin (warf-tmp/smx)

University of Pennsylvania logo

University of Pennsylvania

Status

Terminated

Conditions

Prescribers' Drug Orders

Treatments

Drug: Trimethoprim/Sulfamethoxazole and Warfarin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.

Enrollment

1,971 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

All resident physicians and nurse practitioners involved in inpatient care.

Exclusion criteria

None-

Trial design

1,971 participants in 2 patient groups

computerized alert
Experimental group
Description:
An automatic electronic stop of the tmp/sulfa or warfarin order whenever a resident or nurse practitioner places an order for tmp/sulfa with an already active warfarin order, or when ordering both simultaneously
Treatment:
Drug: Trimethoprim/Sulfamethoxazole and Warfarin
2 Current practice
Other group
Description:
Current practice of the pharmacist recommending cessation of concurrent warfarin and tmp/sulfa orders
Treatment:
Drug: Trimethoprim/Sulfamethoxazole and Warfarin

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems